ORAL-CONTRACEPTIVES AND PLASMA-PROTEIN METABOLISM

[1] ANDERSON D C, 1972, Journal of Endocrinology, V55, pXI

[2] ANDERSON DW, 1978, LANCET, V1, P819

[3] PREPARATION OF A MONOSPECIFIC ANTISERUM TO THYROXINE BINDING GLOBULIN FOR ITS QUANTITATION BY ROCKET IMMUNOELECTROPHORESIS [J]. CLINICA CHIMICA ACTA, 1976, 71 (03) : 501 - 510

[4] BRIGGS M, 1976, ADV STEROID BIOCHEM, V5, P65

[5] BRIGGS M. H., 1970, Advances in Steroid Biochemistry and Pharmacology, V2, P111

[6] BRIGGS MH, 1978, ANNUAL RES REV ORAL, V2, P87

[7] BRIGGS MH, 1977, ANNUAL RES REV ORAL, P45

[8] BRIGGS MH, 1978, 6TH P AS OC C END, V1, P114

[9] BRIGGS MH, 1978, RISKS BENEFITS CONTR, P214

[10] CROWELL EB, 1971, J LAB CLIN MED, V77, P551

[1] ANDERSON D C, 1972, Journal of Endocrinology, V55, pXI

[2] ANDERSON DW, 1978, LANCET, V1, P819

[3] PREPARATION OF A MONOSPECIFIC ANTISERUM TO THYROXINE BINDING GLOBULIN FOR ITS QUANTITATION BY ROCKET IMMUNOELECTROPHORESIS [J]. CLINICA CHIMICA ACTA, 1976, 71 (03) : 501 - 510

[4] BRIGGS M, 1976, ADV STEROID BIOCHEM, V5, P65

[5] BRIGGS M. H., 1970, Advances in Steroid Biochemistry and Pharmacology, V2, P111

[6] BRIGGS MH, 1978, ANNUAL RES REV ORAL, V2, P87

[7] BRIGGS MH, 1977, ANNUAL RES REV ORAL, P45

[8] BRIGGS MH, 1978, 6TH P AS OC C END, V1, P114

[9] BRIGGS MH, 1978, RISKS BENEFITS CONTR, P214

[10] CROWELL EB, 1971, J LAB CLIN MED, V77, P551